Cite
MLA Citation
P. Taylor et al.. “FRI0163 Efficacy of The Biosimilar BOW015, Compared To Originator Infliximab, Initiated at Moderate and Severe Disease Activity Thresholds in Rheumatoid Arthritis.” Annals of the rheumatic diseases, vol. 75, n.d., pp. 488–489. http://access.bl.uk/ark:/81055/vdc_100135133706.0x00004e